Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas Pamela L. BeattyRick van der GeestOlivera J. Finn Original Article 22 April 2016 Pages: 771 - 778
Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors Anja DererBenjamin FreyUdo S. Gaipl Focussed Research Review 21 November 2015 Pages: 779 - 786
Improving cancer immunotherapy with DNA methyltransferase inhibitors Mohammad H. SalehLei WangMichael S. Goldberg Focussed Research Review 08 December 2015 Pages: 787 - 796
PD-L1-specific T cells Shamaila Munir AhmadTroels Holz BorchMads Hald Andersen Focussed Research Review 02 January 2016 Pages: 797 - 804
Lessons learned from cancer vaccine trials and target antigen choice Lisa H. Butterfield Focussed Research Review 03 February 2016 Pages: 805 - 812
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy Suresh Gopi KalathilYasmin Thanavala Focussed Research Review 24 February 2016 Pages: 813 - 819
Tumor-derived factors modulating dendritic cell function Jinbao ZongAnton A. KeskinovMichael R. Shurin Focussed Research Review 16 March 2016 Pages: 821 - 833
Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice Anna K. KozlowskaKawaljit KaurAnahid Jewett Focussed Research Review 31 March 2016 Pages: 835 - 845
How frequently are predicted peptides actually recognized by CD8 cells? Ioana MoldovanOleg TargoniPaul V. Lehmann Focussed Research Review Open access 23 April 2016 Pages: 847 - 855
Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy Michal Baniyash Focussed Research Review 25 May 2016 Pages: 857 - 867
Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells Leena ChaudhuriRupesh K. SrivastavaProtul A. Shrikant Focussed Research Review 06 June 2016 Pages: 869 - 874
Redefining cancer immunotherapy—optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27–30, 2015, Ljubljana, Slovenia Natalia AptsiauriAnahid JewettViktor Umansky Meeting Report 25 January 2016 Pages: 875 - 883